Dasatinib, a selective tyrosine kinase inhibitor, prevents joint destruction in rheumatoid arthritis animal model.

Min, Hong Ki; Kim, Se Hee; Won, Ji-Yeon; Kim, Kyoung-Woon; Lee, Ji-Yeon; Lee, Sang-Heon; Kim, Hae-Rim

Min, Hong Ki; Kim, Se Hee; Won, Ji-Yeon; Kim, Kyoung-Woon; Lee, Ji-Yeon; Lee, Sang-Heon; Kim, Hae-Rim.

Affiliation

Min HK; Division of Rheumatology, Department of Internal Medicine, Konkuk University Medical Center, Seoul, Korea.
Kim SH; Division of Rheumatology, Department of Internal Medicine, Konkuk University Medical Center, Seoul, Korea.
Won JY; R&D Center, OncoInsight, Seoul, Korea.
Kim KW; R&D Center, OncoInsight, Seoul, Korea.
Lee JY; The Rheumatism Research Center, Research Institute of Medical Science, Konkuk University School of Medicine, Seoul, Korea.
Lee SH; Division of Rheumatology, Department of Internal Medicine, Research Institute of Medical Science, Konkuk University School of Medicine, Seoul, Korea.
Kim HR; Division of Rheumatology, Department of Internal Medicine, Research Institute of Medical Science, Konkuk University School of Medicine, Seoul, Korea.

Int J Rheum Dis ; 26(4): 718-726, 2023 Apr.

Article de En | MEDLINE | ID: mdl-36808837

Sujet(s)
Mots clés

dasatinib; osteoclast; regulatory T cell; rheumatoid arthritis; tyrosine kinase inhibitor

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Arthrite expérimentale / Polyarthrite rhumatoïde Type d'étude: Prognostic_studies Limites: Animals / Humans Langue: En Journal: Int J Rheum Dis Sujet du journal: REUMATOLOGIA Année: 2023 Type de document: Article Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google